Skip to main content
. 2020 May 5;12:435–445. doi: 10.2147/CLEP.S229266

Figure 3.

Figure 3

Cumulative incidence of therapies recommended in the first-line setting among patients with primary ITP in the United States, by time since ITP diagnosis.